查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930054

全球生命科學分析市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的考量因素以及未來預測（2025-2034）

Life Science Analytics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 請詢問到貨日

價格

生命科學分析市場的成長驅動因素

預計2025年，全球生命科學分析市場規模將達到137.8億美元，2026年將成長至150億美元，最終到2034年將達到357億美元，在預測期內維持11.45%的強勁複合年增長率。北美將在2025年以43.3%的市佔率引領市場，這主要得益於高額的研發投入、強大的醫療保健IT基礎設施以及先進分析技術在臨床試驗中的廣泛應用。

生命科學分析涵蓋了製藥公司、生物技術公司和合約研究組織（CRO）用於優化藥物發現、臨床試驗、個人化醫療和營運效率的軟體、解決方案和分析應用程式。市場主要參與者包括 Oracle 公司、SAS 研究所、埃森哲、Viva Systems 和 IBM。人工智慧、機器學習和雲端分析平台的日益普及正在推動市場成長。

例如，Oracle 於 2024 年 10 月發布了 Oracle Analytics Intelligence，這是一款面向生命科學領域的人工智慧解決方案，能夠從各種資料來源中快速提取洞察，從而加速開發更精準的治療方法。

市場動態

市場驅動因素

臨床試驗中分析工具的日益普及正在改善患者招募、即時監測和個人化治療方案的開發。利用 SAS 生命科學分析框架和 ClinACT 等分析平台加速臨床前試驗（評估療效、毒性和安全性）正在降低藥物研發的成本和時間。策略夥伴關係，例如 Clarivate 與 VeriSIM Life 的合作（2023 年 12 月）以及 IQVIA 的 "One Home for Sites" 服務的推出（2024 年 6 月），正在進一步促進數據分析和臨床營運效率的提升。

此外，醫院對醫療數據管理平台的日益普及以及醫療支出的成長也推動了市場成長。例如，預計到 2028 年，美國全國醫療支出將達到 6.3 兆美元，這將推動對用於監管合規、成本效益評估和營運效率的分析平台的需求。

市場限制因子

高昂的實施成本（從 10 萬美元到 125 萬美元不等）以及對資料外洩的擔憂限制了其普及。雖然基於雲端的分析效率很高，但也存在網路安全風險。例如，預計到 2022 年，大規模資料外洩的平均成本將增加至 2.41 億美元，凸顯了資料安全的重要性。

機會

在新興市場，醫療基礎設施的建設和數位化技術的進步正在創造豐厚的機會。各公司正在投資分析解決方案，以拓展到印度、中國和非洲等服務不足的地區。例如，PBR Life Sciences（2024 年 12 月）獲得了 100 萬美元的融資，用於在非洲擴展其醫療分析工具。

挑戰

資料整合複雜性、熟練專業人員短缺以及嚴格的監管合規要求仍然是生命科學分析工具在全球營運中部署的挑戰。

市場區隔

按類型劃分：到 2026 年，服務將佔領先地位，市場佔有率達 61.7%，這主要得益於臨床試驗、藥物研發和監管合規領域的廣泛應用。軟體解決方案預計將穩定成長，這得益於 Axtria 的人工智慧驅動解決方案等創新技術（2024 年 3 月發布）。

以交付方式劃分：到 2026 年，隨選/雲端服務將佔榜首，市佔率達 53.08%。在製藥公司和合約研究組織 (CRO) 的推動下，這些服務能夠提高營運效率並加速臨床試驗分析。

按應用劃分：到 2026 年，臨床研究分析將佔 53.44% 的市場佔有率，這主要得益於藥物研發、臨床試驗和研究領域的應用。對精準醫療和營運效率日益增長的需求也推動了商業分析、個人化醫療和供應鏈分析的成長。

按最終用戶劃分：製藥和生物技術公司將在2026年佔40.09%的市場佔有率，憑藉持續的研發投入，繼續保持領先地位。合約研究組織（CRO）和醫療器材公司正經歷顯著成長，尤其是在個人化醫療和分析解決方案的擴展方面。

區域分析

北美市場在2025年以59.7億美元的規模領先，預計到2026年將達到59.5億美元，這主要得益於其完善的研發中心和分析工具的廣泛應用。歐洲緊追在後，在醫療保健分析領域投入大量資金。英國市場預計2026年將達到8.6億美元，德國緊追在後，達到10.1億美元。亞太地區預計將呈現最高的成長率，這得益於新興的醫療保健基礎設施、臨床試驗以及在印度、中國和日本的投資。拉丁美洲市場呈現穩定成長，而中東和非洲地區由於應用有限但投資機會不斷增加，成長速度放緩。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 生命科學分析領域的技術進步
  • 關鍵產業趨勢：併購、業務合作
  • 新產品發布
  • 新冠疫情對市場的影響

第五章 全球生命科學分析市場分析：洞察與預測 （2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 軟體與解決方案
    • 服務
  • 市場分析、洞察與預測：以交付方式劃分
    • 本地部署
    • 按需部署
  • 市場分析、洞察與預測：依應用劃分
    • 商業分析
    • 個人化治療
    • 臨床研究分析
    • 供應鏈分析
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫療器材製造商
    • 製藥與生技公司
    • 合約研究組織 (CRO)
    • 其他
  • 市場分析、洞察與預測：按地區劃分
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美生命科學分析市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲生命科學分析市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太生命科學分析市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太其他地區

第九章：拉丁美洲生命科學分析市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲生命科學分析市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東其他地區非洲

第十一章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
  • SAS Institute Inc.
  • 埃森哲
  • Veeva Systems
  • IBM
  • Oracle
  • Analytics8
  • IQVIA Inc.
  • 其他主要參與者
Product Code: FBI108603

Growth Factors of life science analytics Market

The global life science analytics market was valued at USD 13.78 billion in 2025 and is projected to grow to USD 15 billion in 2026, ultimately reaching USD 35.7 billion by 2034, exhibiting a robust CAGR of 11.45% during the forecast period. North America led the market in 2025 with a 43.3% share, driven by high R&D investment, strong healthcare IT infrastructure, and widespread adoption of advanced analytics in clinical trials.

Life science analytics encompasses software, solutions, and analytical applications that enable pharmaceutical, biotechnology, and contract research organizations (CROs) to optimize drug discovery, clinical trials, personalized therapies, and operational efficiency. Major players in the market include Oracle Corporation, SAS Institute Inc., Accenture, Veeva Systems Inc., and IBM, among others. The growing adoption of AI, machine learning, and cloud-based analytics platforms is fueling market expansion.

For example, in October 2024, Oracle launched AI-powered Oracle Analytics Intelligence for life sciences, enabling faster insights from diverse data sources, thus accelerating the development of therapies with greater precision.

Market Dynamics

Growth Factors:

The increasing use of analytical tools in clinical trials is improving patient recruitment, real-time monitoring, and development of personalized therapies. Preclinical studies for efficacy, toxicity, and safety assessment are being accelerated using analytical platforms like SAS Life Science Analytics Framework and ClinACT, reducing both cost and time for drug development. Strategic partnerships such as Clarivate and VeriSIM Life (December 2023) and IQVIA's 'One Home for Sites' (June 2024) are further enhancing the efficiency of data analysis and clinical operations.

Additionally, the growing adoption of healthcare data management platforms in hospitals, coupled with rising healthcare expenditures, supports market growth. For instance, the U.S. National Healthcare Expenditure is projected to reach USD 6.3 trillion by 2028, driving demand for analytics platforms for regulatory compliance, cost-effectiveness assessment, and operational efficiency.

Restraints:

High implementation costs, which may range from USD 100,000 to USD 1.25 million, and concerns over data breaches are restraining adoption. Cloud-based analytics, while efficient, also pose cybersecurity risks. For example, the average cost of a mega data breach increased to USD 241 million in 2022, highlighting the importance of data security.

Opportunities:

Emerging markets present lucrative opportunities due to rising healthcare infrastructure and digitalization. Companies are investing in analytics solutions to penetrate untapped regions such as India, China, and Africa. For instance, PBR Life Sciences (December 2024) secured USD 1 million funding to expand healthcare analytics tools in Africa.

Challenges:

Data integration complexities, shortage of skilled professionals, and stringent regulatory compliance requirements remain challenges in deploying life science analytics tools across global operations.

Market Segmentation

By Type: Services dominated with a 61.7% share in 2026, driven by widespread adoption in clinical trials, drug development, and regulatory compliance. Software & solutions are expected to grow steadily, supported by innovations such as Axtria's AI-driven solutions (March 2024).

By Delivery: On-demand/cloud services led with 53.08% share in 2026, fueled by adoption in pharmaceutical companies and CROs, enabling streamlined operations and faster clinical trial analysis.

By Application: Clinical research analytics held a 53.44% share in 2026, driven by adoption in drug development, clinical trials, and research. Commercial analytics, personalized therapy, and supply chain analytics segments are also experiencing growth due to rising demand for precision medicine and operational efficiency.

By End-Users: Pharma & biotech companies dominated with a 40.09% share in 2026, owing to continuous investment in R&D. CROs and medical device companies are witnessing substantial growth, particularly with increasing adoption of personalized medicine and analytics solutions.

Regional Insights

North America led with USD 5.97 billion in 2025, projected to reach USD 5.95 billion in 2026, driven by established R&D centers and adoption of analytical tools. Europe follows with strong funding for healthcare analytics; the UK market is projected at USD 0.86 billion in 2026, Germany at USD 1.01 billion. Asia Pacific is expected to register the highest growth, supported by emerging healthcare infrastructure, clinical trials, and investments in India, China, and Japan. Latin America shows steady growth, while the Middle East & Africa grow slower due to limited adoption but emerging investment opportunities.

Competitive Landscape

Key players include Oracle, Accenture, SAS Institute, IQVIA, Veeva Systems, and IBM, focusing on collaborations, acquisitions, and technological innovations to expand market share. Notable developments include Accenture's acquisition of consus.health (August 2024) and Oracle's CancerMPact service (September 2024) for global cancer treatment trend analysis.

Conclusion

The global life science analytics market is on a strong growth trajectory, expanding from USD 13.78 billion in 2025 to USD 15 billion in 2026 and expected to reach USD 35.7 billion by 2034 at a CAGR of 11.45%. The market is driven by the growing adoption of AI, cloud services, and advanced analytics in pharma, biotech, and CROs for drug development, clinical research, and personalized medicine. North America continues to lead, while Asia Pacific offers the fastest growth potential. Despite challenges such as high implementation costs, data integration issues, and regulatory compliance, technological innovations, strategic partnerships, and the rising demand for cloud-based services and personalized therapies are poised to sustain market expansion and transform the life sciences industry globally.

Segmentation By Type

  • Software & Solutions
  • Services

By Delivery

  • On-premise
  • On-demand

By Application

  • Commercial Analytics
  • Personalized Therapy
  • Clinical Research Analytics
  • Supply Chain Analytics

By End User

  • Medical Device Companies
  • Pharma & Biotech Companies
  • Contract Research Organizations
  • Others

By Region

  • North America (By Type, By Delivery, By Application, By End Users, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of the Asia Pacific
  • Latin America (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Life Science Analytics
  • 4.2. Key Industry Developments- Mergers, Acquisitions & Partnerships
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on the Market

5. Global Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Software & Solutions
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Delivery
    • 5.2.1. On-premise
    • 5.2.2. On-demand
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Commercial Analytics
    • 5.3.2. Personalized Therapy
    • 5.3.3. Clinical Research Analytics
    • 5.3.4. Supply Chain Analytics
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Medical Device Companies
    • 5.4.2. Pharma & Biotech Companies
    • 5.4.3. Contract Research Organizations
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa

6. North America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Software & Solutions
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Delivery
    • 6.2.1. On-premise
    • 6.2.2. On-demand
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Commercial Analytics
    • 6.3.2. Personalized Therapy
    • 6.3.3. Clinical Research Analytics
    • 6.3.4. Supply Chain Analytics
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Medical Device Companies
    • 6.4.2. Pharma & Biotech Companies
    • 6.4.3. Contract Research Organizations
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Software & Solutions
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Delivery
    • 7.2.1. On-premise
    • 7.2.2. On-demand
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Commercial Analytics
    • 7.3.2. Personalized Therapy
    • 7.3.3. Clinical Research Analytics
    • 7.3.4. Supply Chain Analytics
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Medical Device Companies
    • 7.4.2. Pharma & Biotech Companies
    • 7.4.3. Contract Research Organizations
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Software & Solutions
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Delivery
    • 8.2.1. On-premise
    • 8.2.2. On-demand
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Commercial Analytics
    • 8.3.2. Personalized Therapy
    • 8.3.3. Clinical Research Analytics
    • 8.3.4. Supply Chain Analytics
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Medical Device Companies
    • 8.4.2. Pharma & Biotech Companies
    • 8.4.3. Contract Research Organizations
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. South Korea
    • 8.5.6. Rest of Asia Pacific

9. Latin America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Software & Solutions
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Delivery
    • 9.2.1. On-premise
    • 9.2.2. On-demand
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Commercial Analytics
    • 9.3.2. Personalized Therapy
    • 9.3.3. Clinical Research Analytics
    • 9.3.4. Supply Chain Analytics
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Medical Device Companies
    • 9.4.2. Pharma & Biotech Companies
    • 9.4.3. Contract Research Organizations
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Software & Solutions
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Delivery
    • 10.2.1. On-premise
    • 10.2.2. On-demand
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Commercial Analytics
    • 10.3.2. Personalized Therapy
    • 10.3.3. Clinical Research Analytics
    • 10.3.4. Supply Chain Analytics
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Medical Device Companies
    • 10.4.2. Pharma & Biotech Companies
    • 10.4.3. Contract Research Organizations
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. SAS Institute Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. SWOT Analysis
      • 11.2.1.3. Recent Developments
      • 11.2.1.4. Strategies
      • 11.2.1.5. financials (Based on Availability)
    • 11.2.2. Accenture
      • 11.2.2.1. Overview
      • 11.2.2.2. SWOT Analysis
      • 11.2.2.3. Recent Developments
      • 11.2.2.4. Strategies
      • 11.2.2.5. financials (Based on Availability)
    • 11.2.3. Veeva Systems
      • 11.2.3.1. Overview
      • 11.2.3.2. SWOT Analysis
      • 11.2.3.3. Recent Developments
      • 11.2.3.4. Strategies
      • 11.2.3.5. financials (Based on Availability)
    • 11.2.4. IBM
      • 11.2.4.1. Overview
      • 11.2.4.2. SWOT Analysis
      • 11.2.4.3. Recent Developments
      • 11.2.4.4. Strategies
      • 11.2.4.5. financials (Based on Availability)
    • 11.2.5. Oracle
      • 11.2.5.1. Overview
      • 11.2.5.2. SWOT Analysis
      • 11.2.5.3. Recent Developments
      • 11.2.5.4. Strategies
      • 11.2.5.5. financials (Based on Availability)
    • 11.2.6. Analytics8
      • 11.2.6.1. Overview
      • 11.2.6.2. SWOT Analysis
      • 11.2.6.3. Recent Developments
      • 11.2.6.4. Strategies
      • 11.2.6.5. financials (Based on Availability)
    • 11.2.7. IQVIA Inc
      • 11.2.7.1. Overview
      • 11.2.7.2. SWOT Analysis
      • 11.2.7.3. Recent Developments
      • 11.2.7.4. Strategies
      • 11.2.7.5. financials (Based on Availability)
    • 11.2.8. Other Prominent Players
      • 11.2.8.1. Overview
      • 11.2.8.2. SWOT Analysis
      • 11.2.8.3. Recent Developments
      • 11.2.8.4. Strategies
      • 11.2.8.5. financials (Based on Availability)

List of Tables

  • Table 01: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 03: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 04: Global Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 05: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 06: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 07: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 08: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 09: North America Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 12: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 13: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 16: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 17: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 18: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 21: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 23: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 26: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 27: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 28: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Life Science Analytics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Life Science Analytics Market Revenue Share (%), By Type, 2025 & 2034
  • Figure 03: Global Life Science Analytics Market Revenue Share (%), By Delivery, 2025 & 2034
  • Figure 04: Global Life Science Analytics Market Revenue Share (%), By Application, 2025 & 2034
  • Figure 05: Global Life Science Analytics Market Revenue Share (%), By End User, 2025 & 2034
  • Figure 06: Global Life Science Analytics Market Value (USD billion), By Region, 2025 & 2034
  • Figure 07: North America Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 08: North America Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 09: North America Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 10: North America Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 11: North America Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 13: North America Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 15: North America Life Science Analytics Market Value (USD billion), by Country, 2025 & 2034
  • Figure 16: North America Life Science Analytics Market Value Share (%), by Country, 2025
  • Figure 17: Europe Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 19: Europe Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 20: Europe Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 21: Europe Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 23: Europe Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 25: Europe Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 27: Asia Pacific Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 30: Asia Pacific Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 31: Asia Pacific Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 37: Latin America Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 40: Latin America Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 41: Latin America Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 50: Middle East & Africa Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 51: Middle East & Africa Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 57: Global Life Science Analytics Market Share (%), 2025